Stem cell patch repairs hearts without surgery
Mayo Clinic develops a stem cell patch to repair damaged hearts without open-heart surgery, showing promise in preclinical tests.
Why it matters
- Offers a less invasive option for heart failure treatment.
- Could revolutionize treatment for severe heart failure patients.
By the numbers
- Preclinical testing showed improved heart function and healing.
- Human clinical trials could start in five years.
The big picture
- The patch uses lab-grown heart tissue from stem cells.
- Delivered through a tiny incision, avoiding open-heart surgery.
What they're saying
- Testing was likely done in animals (mice or rats).
- Hopes it will translate to human applications.
Caveats
- Preclinical testing only; not yet tested in humans.
What’s next
- Larger-scale preclinical testing planned.
- Human clinical trials estimated to start in five years.